July 22, 2025
All resources
Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
Filter by
March 19, 2025
September 11, 2024
September 11, 2024
IMC Response to the PMPRB’s 2024 discussion guide on the board’s guidelines
July 02, 2024
April 16, 2024
January 04, 2024
September 08, 2023
August 21, 2023
December 05, 2022
December 05, 2022
The Suspension and reformulation of the PMPRB guidelines is urgently required: IMC response to PMPRB 2022 guidelines proposals
Innovative Medicines Canada has submitted formal feedback to the Patented Medicine Prices Review Board’s (PMPRB) revised Draft Guidelines public consultation, calling for a suspension of the planned implementation to ensure meaningful stakeholder consultation and a thorough impact analysis.
July 20, 2022
July 20, 2022
IMC response to PMPRB interim approach consultation
IMC’s members continue to have significant concerns regarding changes to the PMPRB and future Guidelines that will implement the revised schedule of international reference countries.
August 31, 2021
August 31, 2021
PMPRB notice and comment response
Innovative Medicines Canada opposes a July 15, 2021 proposal to change international price tests for existing medicines and their line extensions from the highest of the international schedule to the median.
June 21, 2021
June 21, 2021
Proposed guidelines monitoring and evaluation plan
This submission responds to PMPRB’s consultation on its proposed Guideline Monitoring and Evaluation Plan GMEP, deeming it premature.
